Redwood AI Shares Gain DTC Eligibility, Boosting U.S. Investor Access

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) has achieved a significant milestone by obtaining Depository Trust Company (DTC) eligibility for its common shares. This approval streamlines electronic clearing and settlement for U.S. investors, making it easier for them to trade Redwood AI shares through brokerage firms. CEO Louis Dron highlighted that DTC eligibility enhances share liquidity and broadens access for American investors, a crucial step for the company as it advances its artificial intelligence-driven chemistry R&D platform. The platform aims to accelerate drug discovery and development, as well as defense and safety solutions, by integrating AI with chemistry expertise to streamline drug synthesis and scale-up processes.

In tandem with this development, Redwood AI has engaged InvestorBrandNetwork (IBN) to boost market awareness and corporate communications. Under a contract running through September 30, 2026, or until the allocated budget is exhausted, IBN will provide services including editorial coverage, newsletter distribution, social media support, and podcast syndication. Redwood AI will pay IBN a cash fee of $114,000 for these services, with no securities issued as compensation. This move underscores the company's commitment to increasing its visibility among investors and the broader market.

Redwood AI's core mission is to leverage advanced artificial intelligence to accelerate chemistry R&D, with a focus on drug discovery and development, as well as defense and safety solutions. By combining expertise in chemistry, AI, and manufacturing, the company aims to enable faster and more efficient development of new therapies and chemistry-driven applications. The DTC eligibility and engagement with IBN are strategic steps to enhance investor access and market presence as Redwood AI continues to innovate in the AI and chemistry space.